Goldman Sachs Upgrades Immunocore Hldgs to Buy

Goldman Sachs analyst Rajan Sharma upgrades Immunocore Hldgs (NASDAQ:IMCR) from Neutral to Buy.

Goldman Sachs analyst Rajan Sharma upgrades Immunocore Hldgs (NASDAQ:IMCR) from Neutral to Buy.

Total
0
Shares
Related Posts